Biotech Co. Inflated R&D Claim By $1.2M, 4th Circ. Told
By Anna Scott Farrell · October 17, 2023, 5:14 PM EDT
A biotechnology company that claimed tax credits for increasing its scientific research improperly excluded $26.6 million in clinical testing expenses from its baseline calculation, juicing its claim by $1.2 million, the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login